drugset / Trial / NCT03797196

Summary

Open label, randomized, multicenter, intervention trial comparing standard immunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen in combination with everolimus. The primary objective is to test the hypothesis that an age-adapted immunosuppressive regimen targeted at reduced immunosuppression with low calcineurin inhibitor (tacrolimus) exposure in combination with everolimus will result in improved outcome in elderly recipients of A: Kidneys from older deceased donors (\>64 years) and B: Kidneys from living donors (all ages) and younger deceased donors (\<65 years).

Timeline

Start
2019-07-29
Primary completion
2025-06
Completion
2026-12

Outcome

Missed primary endpoint

paper successful transplantation at 2 years between the groups (TEP 94 [50%], TMP 110 [57%]; difference 7% [95% confidence interval, -17 to 3] P = 0.91). PMID 41201871 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule — —
Comparator Mycophenolate Mofetil Small molecule — —
Subject Tacrolimus Small molecule — —